Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 561–580 of 703 recalls
Glenmark Pharmaceuticals Inc., USA
CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
Glenmark Pharmaceuticals Inc., USA
CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm